We previously identified sex‐determining region Y (SRY)‐box transcription factor (SOX9) as a transcription factor that serves as a prognostic biomarker, particularly in BCL2‐overexpressing DLBCL, and plays a vital role in lymphomagenesis. Here, BCL2 is linked to diffuse large B-cell lymphoma.